September 2026
Largest Medical Imaging & Diagnostics Public Companies in the UK
Benchmark revenue and EBITDA valuation multiples for public comps like
NIOX Group, EKF Diagnostics, TeraView Holdings, EDX Medical Group and Feedback.
 | NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world. | $1 | -8% | $378M | $353M | 5.5x | 17.8x | ||
| EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements. | $0 | -16% | $146M | $131M | 1.9x | 8.0x | ||
| TeraView Holdings PLC is a holding company. It provides specialized solutions for semiconductor packaging, automotive painting and high-value-added coating, and lithium-ion batteries, leveraging non-destructive testing and measurement technology utilizing terahertz (THz) frequencies. The company offers customized solutions for each industry based on its accumulated technological prowess and is expanding into various markets. Its product offerings include EOTPR, TeraCota 3000, TeraCota 3500, and TeraPulse. The maximum revenue is being generated from EOTPR (Electro-Optical Terahertz Pulse Reflectometry), which is a solution for non-destructively diagnosing various defects occurring in the semiconductor packaging process. | $2 | -- | $82M | $63M | 3.6x | - | ||
| EDX Medical Group PLC is principally engaged in the business of creating health testing solutions and developing biological and digital technologies to improve the detection of diseases and disorders. It develops and provides digital diagnostic products and services for testing in areas including cancer, cardiovascular disease, neurology, and infectious diseases. It operates a molecular biology and diagnostics laboratory in Cambridge, UK, from which it performs research & development, and provides testing and genomic sequencing services. It has two operating segments: Medical goods and Medical services. The majority of revenue is generated from the Medical goods segment. Geographically, all revenue was derived from the United Kingdom. | $0 | -- | $52M | $48M | 108.9x | (6.5x) | ||
| Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making, and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. Its operating segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa, a regulated communication platform for sharing clinical results and supporting multidisciplinary teamwork, and CareLocker, a patient-facing platform that provides access and control over diagnostic and clinical data. | $0 | -42% | $4M | - | - | - | ||
| Median | $0 | -16% | $82M | $97M | 4.5x | 8.0x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.